![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Plk5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PLK5 mRNA | CTD | PMID:36331819 | Plk5 | Rat | 17beta-estradiol | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | Estradiol results in decreased expression of PLK5 mRNA | CTD | PMID:39298647 | Plk5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLK5 mRNA | CTD | PMID:33956508 | Plk5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLK5 mRNA | CTD | PMID:33387578 | Plk5 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of PLK5 mRNA | CTD | PMID:39298647 | Plk5 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of PLK5 mRNA | CTD | PMID:24780913 and PMID:25825206 | Plk5 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of PLK5 mRNA | CTD | PMID:31881176 | Plk5 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of PLK5 mRNA | CTD | PMID:28959563 | Plk5 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of PLK5 mRNA | CTD | PMID:23630614 | Plk5 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLK5 mRNA | CTD | PMID:36189433 | Plk5 | Rat | arsane | decreases expression | ISO | PLK5 (Homo sapiens) | 6480464 | Arsenic results in decreased expression of PLK5 mRNA | CTD | PMID:36861143 | Plk5 | Rat | arsenic atom | decreases expression | ISO | PLK5 (Homo sapiens) | 6480464 | Arsenic results in decreased expression of PLK5 mRNA | CTD | PMID:36861143 | Plk5 | Rat | benzo[a]pyrene | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA | CTD | PMID:27858113 | Plk5 | Rat | benzo[a]pyrene | increases methylation | ISO | PLK5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of PLK5 promoter | CTD | PMID:27901495 | Plk5 | Rat | benzo[b]fluoranthene | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA | CTD | PMID:27858113 | Plk5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PLK5 mRNA | CTD | PMID:25181051 | Plk5 | Rat | bisphenol A | decreases methylation | ISO | PLK5 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of PLK5 gene | CTD | PMID:31601247 | Plk5 | Rat | bisphenol F | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of PLK5 mRNA | CTD | PMID:38685157 | Plk5 | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of PLK5 mRNA | CTD | PMID:19167457 | Plk5 | Rat | cadmium dichloride | decreases expression | ISO | PLK5 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of PLK5 mRNA | CTD | PMID:38382870 | Plk5 | Rat | carbon nanotube | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | Plk5 | Rat | chrysene | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA | CTD | PMID:27858113 | Plk5 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of PLK5 mRNA | CTD | PMID:26577399 | Plk5 | Rat | DDE | decreases expression | ISO | PLK5 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of PLK5 mRNA | CTD | PMID:38568856 | Plk5 | Rat | dibenz[a,h]anthracene | increases expression | ISO | Plk5 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | Plk5 | Rat | genistein | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | Genistein results in decreased expression of PLK5 mRNA | CTD | PMID:32186404 | Plk5 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of PLK5 mRNA | CTD | PMID:33387578 | Plk5 | Rat | inulin | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PLK5 mRNA | CTD | PMID:36331819 | Plk5 | Rat | Licochalcone B | increases expression | ISO | PLK5 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of PLK5 mRNA | CTD | PMID:33647349 | Plk5 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PLK5 mRNA | CTD | PMID:36189433 | Plk5 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PLK5 mRNA | CTD | PMID:33387578 | Plk5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PLK5 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PLK5 mRNA | CTD | PMID:36331819 | Plk5 | Rat | pirinixic acid | decreases expression | ISO | Plk5 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of PLK5 mRNA | CTD | PMID:23811191 | Plk5 | Rat | sodium arsenite | increases expression | ISO | PLK5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of PLK5 mRNA | CTD | PMID:38568856 | Plk5 | Rat | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of PLK5 mRNA | CTD | PMID:19281266 | Plk5 | Rat | tetraphene | multiple interactions | ISO | Plk5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA | CTD | PMID:27858113 | Plk5 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of PLK5 mRNA | CTD | PMID:34492290 | Plk5 | Rat | titanium dioxide | affects expression | ISO | Plk5 (Mus musculus) | 6480464 | titanium dioxide affects the expression of PLK5 mRNA | CTD | PMID:23557971 | Plk5 | Rat | titanium dioxide | decreases methylation | ISO | Plk5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PLK5 gene and titanium dioxide results in decreased methylation of PLK5 promoter alternative form | CTD | PMID:35295148 | Plk5 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of PLK5 mRNA | CTD | PMID:33387578 | Plk5 | Rat | triptonide | increases expression | ISO | Plk5 (Mus musculus) | 6480464 | triptonide results in increased expression of PLK5 mRNA | CTD | PMID:33045310 | Plk5 | Rat | valproic acid | increases methylation | ISO | PLK5 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of PLK5 gene | CTD | PMID:29154799 | |